Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Up 150.0% in December

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 17,500 shares, a growth of 150.0% from the November 30th total of 7,000 shares. Based on an average daily volume of 24,300 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.3% of the company’s shares are sold short.

Cocrystal Pharma Price Performance

Shares of COCP stock opened at $3.09 on Friday. The company has a 50-day moving average of $2.04 and a two-hundred day moving average of $2.02. The firm has a market cap of $31.44 million, a PE ratio of -1.67 and a beta of 1.52. Cocrystal Pharma has a 1-year low of $1.33 and a 1-year high of $3.10.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.